nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A consensus guideline for management of erlotinib-associated cutaneous toxicity in the UK
|
Thatcher, N. |
|
2008 |
60 |
S1 |
p. S24- 1 p. |
artikel |
2 |
Altered expression profiles of PGIS and TXS in NSCLC: regulation of tumour cell growth and invasive potential
|
Cathcart, M.C. |
|
2008 |
60 |
S1 |
p. S8-S9 2 p. |
artikel |
3 |
Anatomy of a phase III clinical trial: vivisecting BTOG2
|
Jarrett, H.W. |
|
2008 |
60 |
S1 |
p. S20-S21 2 p. |
artikel |
4 |
An audit of patient and consultant satisfaction with a lung cancer nurse specialist follow up service
|
Jones, H. |
|
2008 |
60 |
S1 |
p. S12-S13 2 p. |
artikel |
5 |
A nurse led lung cancer clinic reduces patient anxiety and improves understanding
|
Phelps, J. |
|
2008 |
60 |
S1 |
p. S13-S14 2 p. |
artikel |
6 |
A pilot study to explore the benefits of nutritional screening within the outpatient setting
|
Matthews, E. |
|
2008 |
60 |
S1 |
p. S16- 1 p. |
artikel |
7 |
A randomised trial of external beam radiotherapy (EBRT)+/− intraluminal radiotherapy (ILT) in symptomatic NSCLC patients: quality of life and palliation of symptoms
|
Jain, P. |
|
2008 |
60 |
S1 |
p. S27-S28 2 p. |
artikel |
8 |
Assessment of lung cancer related symptoms and treatment related side effects in a group of patients with advanced lung cancer receiving palliative chemotherapy
|
Mannion, E. |
|
2008 |
60 |
S1 |
p. S23- 1 p. |
artikel |
9 |
Assessment of psychological distress in patients with lung cancer receiving palliative chemotherapy
|
Mannion, E. |
|
2008 |
60 |
S1 |
p. S23-S24 2 p. |
artikel |
10 |
Assessment of smoking habits in patients undergoing initial investigation for possible lung cancer
|
Ghosal, R. |
|
2008 |
60 |
S1 |
p. S17-S18 2 p. |
artikel |
11 |
Audit of methods of suspected lung cancer presentation to a District General Hospital
|
Adeniji, K. |
|
2008 |
60 |
S1 |
p. S14-S15 2 p. |
artikel |
12 |
Author index
|
|
|
2008 |
60 |
S1 |
p. S31-S33 3 p. |
artikel |
13 |
A very rare case of iris metastases from small cell carcinoma of the lung
|
Hudson, E. |
|
2008 |
60 |
S1 |
p. S3- 1 p. |
artikel |
14 |
Can hyperpolarized 3He MRI detect radiation induced lung damage?
|
Ireland, R.H. |
|
2008 |
60 |
S1 |
p. S28- 1 p. |
artikel |
15 |
Can the negative predictive value of CT-PET for mediastinal lymph node staging in non-small cell lung cancer be trusted?
|
Picozzi, N.M. |
|
2008 |
60 |
S1 |
p. S6- 1 p. |
artikel |
16 |
Chemotherapy in non small cell lung cancer patients with brain metastases
|
White, I. |
|
2008 |
60 |
S1 |
p. S22- 1 p. |
artikel |
17 |
Combined manubrioclavicular approach to a limb saving resection of sarcomas in the thoracic outlet
|
Khoshbin, E. |
|
2008 |
60 |
S1 |
p. S1- 1 p. |
artikel |
18 |
Complying with the national cancer waiting time targets in the context of continuous hyperfractionated radiotherapy (CHART)
|
Klapper, R. |
|
2008 |
60 |
S1 |
p. S27- 1 p. |
artikel |
19 |
Concurrent chemoradiotherapy (ConCRT) in locally advanced (LA) non-small cell Lung Cancer (NSCLC); 3-year experience at the Bank of Cyprus (BoC) oncology centre
|
Decatris, M.P. |
|
2008 |
60 |
S1 |
p. S26- 1 p. |
artikel |
20 |
CONVERT: Concurrent ONce-daily VErsus twice-daily RadioTherapy. A new phase III randomised controlled trial for patients LS SCLC and good performance status
|
Faivre-Finn, C. |
|
2008 |
60 |
S1 |
p. S3-S4 2 p. |
artikel |
21 |
Current survival of surgical resections of lung cancer in the North West of England – a multicenter study
|
Devbhandari, M.P. |
|
2008 |
60 |
S1 |
p. S2- 1 p. |
artikel |
22 |
Demographic and geographic features as prognostic factors in lung cancer patients
|
Quintyne, K.I. |
|
2008 |
60 |
S1 |
p. S13- 1 p. |
artikel |
23 |
Determining internal target volume (ITV) for mobile lung tumours: 2-D kilovoltage (kV) fluoroscopy, 3D or 4D cone-beam CT (CBCT)?
|
Jain, P. |
|
2008 |
60 |
S1 |
p. S28- 1 p. |
artikel |
24 |
Developing a tool to address symptom delay in lung cancer
|
Tod, A.M. |
|
2008 |
60 |
S1 |
p. S17- 1 p. |
artikel |
25 |
Diagnostic accuracy of transbronchial needle aspiration (TBNA) of mediastinal lymph nodes
|
Shareef, M.S. |
|
2008 |
60 |
S1 |
p. S5-S6 2 p. |
artikel |
26 |
Direct intrathoracic cryosurgery: an alternative method to lung resection
|
Hunt, I. |
|
2008 |
60 |
S1 |
p. S2- 1 p. |
artikel |
27 |
Docetaxel first line use in advanced NSCLC
|
Nicolson, M. |
|
2008 |
60 |
S1 |
p. S22- 1 p. |
artikel |
28 |
Does primary chemotherapy in locally advanced non-small cell lung cancer allow down-staging and facilitate further treatment?
|
Lawless, S.E. |
|
2008 |
60 |
S1 |
p. S19- 1 p. |
artikel |
29 |
Do nurses do it better? An evaluation of nurse led follow up clinic for lung cancer (NLFLC)
|
Brown, L. |
|
2008 |
60 |
S1 |
p. S15-S16 2 p. |
artikel |
30 |
Dose intensity in advanced non-small cell lung cancer
|
Brunetto, A. |
|
2008 |
60 |
S1 |
p. S20- 1 p. |
artikel |
31 |
Early intervention in lung cancer within Doncaster (ElCiD)
|
Tod, A.M. |
|
2008 |
60 |
S1 |
p. S17- 1 p. |
artikel |
32 |
Editorial Board
|
|
|
2008 |
60 |
S1 |
p. iii- 1 p. |
artikel |
33 |
Efficacy and tolerability of docetaxel as second line treatment in patients with non-small cell lung cancer: an experience in three centres
|
Micallef, R.A. |
|
2008 |
60 |
S1 |
p. S21- 1 p. |
artikel |
34 |
Epigenetic regulation of the vascular endothelial growth factor receptors: role as a cell survival factor in non-small cell lung cancer
|
Barr, M. |
|
2008 |
60 |
S1 |
p. S10- 1 p. |
artikel |
35 |
Epigenetics underpinning the regulation of the CXC (ELR+) chemokines in NSCLC
|
Baird, A. |
|
2008 |
60 |
S1 |
p. S9- 1 p. |
artikel |
36 |
EP receptors in NSCLC, and their regulation by epigenetic modifications
|
Gray, S.G. |
|
2008 |
60 |
S1 |
p. S11-S12 2 p. |
artikel |
37 |
Erlotinib use in NSCLC: how are we getting on?
|
Nicolson, M. |
|
2008 |
60 |
S1 |
p. S25- 1 p. |
artikel |
38 |
Establishment of a lung cancer biopsy tissue bank
|
Chatterji, S. |
|
2008 |
60 |
S1 |
p. S8- 1 p. |
artikel |
39 |
Fast-track CT scans – are patients treated quicker?
|
Todd, M. |
|
2008 |
60 |
S1 |
p. S16-S17 2 p. |
artikel |
40 |
Fatal exacerbation of stable interstitial pulmonary fibrosis following CHART
|
Duckers, J. |
|
2008 |
60 |
S1 |
p. S28-S29 2 p. |
artikel |
41 |
First two years experience of erlotinib in routine practice in Edinburgh
|
English, J. |
|
2008 |
60 |
S1 |
p. S25- 1 p. |
artikel |
42 |
High dose palliative radiotherapy in NSCLC; 27Gy/6# and 39Gy/13# – is there equivalence?
|
Jain, S. |
|
2008 |
60 |
S1 |
p. S26-S27 2 p. |
artikel |
43 |
IL-20 and its associated receptors in NSCLC
|
Baird, A. |
|
2008 |
60 |
S1 |
p. S9-S10 2 p. |
artikel |
44 |
Incidence of thrombosis in lung cancer
|
Hegde, S. |
|
2008 |
60 |
S1 |
p. S4-S5 2 p. |
artikel |
45 |
Increasing preoperative neutrophil to lymphocyte ratio – an independent predictor of adverse survival after pulmonary resection of NSCLC
|
Sarraf, K. |
|
2008 |
60 |
S1 |
p. S8- 1 p. |
artikel |
46 |
Induction and concurrent chemoradiotherapy for non-small cell lung cancer (NSCLC) using cisplatin and vinorelbine
|
Fuang Ho, G. |
|
2008 |
60 |
S1 |
p. S18- 1 p. |
artikel |
47 |
Induction chemotherapy in non-small cell lung cancer: experience at the Northern Ireland Cancer Centre
|
Johnston, R. |
|
2008 |
60 |
S1 |
p. S19- 1 p. |
artikel |
48 |
Intensity modulated radiotherapy (IMRT) in right sided malignant mesothelioma following extrapleural pneumonectomy
|
Eswar, C. |
|
2008 |
60 |
S1 |
p. S7- 1 p. |
artikel |
49 |
Investigating the link between hypoxia, Akt compartmentalization and cell survival in malignant pleural mesothelioma
|
Gately, K. |
|
2008 |
60 |
S1 |
p. S10-S11 2 p. |
artikel |
50 |
Irinotecan and carboplatin in relapsed small cell lung cancer
|
Forrest, J. |
|
2008 |
60 |
S1 |
p. S4- 1 p. |
artikel |
51 |
Local validation of national lung cancer audit
|
Gregory, D. |
|
2008 |
60 |
S1 |
p. S14- 1 p. |
artikel |
52 |
Long-term survival following resection of colorectal pulmonary metastases
|
Belcher, E. |
|
2008 |
60 |
S1 |
p. S1- 1 p. |
artikel |
53 |
Lung cancer at presentation – then and now
|
Short, N. |
|
2008 |
60 |
S1 |
p. S18- 1 p. |
artikel |
54 |
Lung cancer – the devil is in the detail
|
Khan, B.A. |
|
2008 |
60 |
S1 |
p. S12- 1 p. |
artikel |
55 |
Measurement of individual quality of life in patients with lung cancer receiving palliative chemotherapy
|
Mannion, E. |
|
2008 |
60 |
S1 |
p. S23- 1 p. |
artikel |
56 |
Mesothelioma multi-disciplinary team meeting – effects on quality of care
|
Duckers, J. |
|
2008 |
60 |
S1 |
p. S6-S7 2 p. |
artikel |
57 |
Mitomycin C, vinblastine and carboplatin (MVCarbo) in the treatment of advanced non-small cell lung cancer (NSCLC): an update
|
Hudson, E. |
|
2008 |
60 |
S1 |
p. S20- 1 p. |
artikel |
58 |
Modafinil for the treatment of fatigue in lung cancer: a pilot study
|
Spathis, A. |
|
2008 |
60 |
S1 |
p. S4- 1 p. |
artikel |
59 |
Neo-adjuvant chemotherapy for patients with NSCLC who are inoperable, either because of stage or extent of required resection
|
Eaton, D. |
|
2008 |
60 |
S1 |
p. S18- 1 p. |
artikel |
60 |
Neuropilin-1 blockade inhibits hypoxia-induced Akt and MAPK phosphorylation and induces apoptosis of non-small cell lung cancer cells
|
Barr, M. |
|
2008 |
60 |
S1 |
p. S10- 1 p. |
artikel |
61 |
Nurse led, lung cancer oral chemotherapy clinic
|
McPhelim, J. |
|
2008 |
60 |
S1 |
p. S16- 1 p. |
artikel |
62 |
Optimum technique for CT imaging of pleural disease: a comparison of two contrast infusion protocols
|
Kirke, R. |
|
2008 |
60 |
S1 |
p. S7- 1 p. |
artikel |
63 |
Our experience in the treatment and overall survival of small cell lung cancer patients treated at the Oncology Department of Singleton Hospital, Swansea, UK
|
Chaudhuri, A. |
|
2008 |
60 |
S1 |
p. S3- 1 p. |
artikel |
64 |
Outcome for non-small-cell lung cancer (NSCLC) patients in South East Ireland
|
Quintyne, K.I. |
|
2008 |
60 |
S1 |
p. S13- 1 p. |
artikel |
65 |
Palliative chemotherapy in non-small cell lung cancer; a year's audit of 101 patients
|
Fairmichael, C. |
|
2008 |
60 |
S1 |
p. S19- 1 p. |
artikel |
66 |
Pemetrexed lung: a new entity?
|
Khan, B.A. |
|
2008 |
60 |
S1 |
p. S21- 1 p. |
artikel |
67 |
PET-CT after 50–60 Gy in NSCLC as a means of planning dose escalation
|
Gillham, C. |
|
2008 |
60 |
S1 |
p. S30- 1 p. |
artikel |
68 |
Positive trends in diagonosis of maligant pleural mesothelioma: a six year experience in Leicestershire
|
Bajaj, A. |
|
2008 |
60 |
S1 |
p. S7- 1 p. |
artikel |
69 |
Pre-clinic staging CT scan in patients with suspected thoracic malignancy
|
Raj, J.V. |
|
2008 |
60 |
S1 |
p. S5- 1 p. |
artikel |
70 |
Preoperative versus postoperative chemotherapy for patients undergoing resection for lung cancer. Systematic review and indirect comparison meta-analysis of randomised trials
|
Lim, E. |
|
2008 |
60 |
S1 |
p. S19- 1 p. |
artikel |
71 |
Prolonged remission in patients with extensive central nervous system metastasis treated with erlotinib
|
Webster, R. |
|
2008 |
60 |
S1 |
p. S24-S25 2 p. |
artikel |
72 |
Promoting lung cancer awareness in secondary schools
|
Draffan, J. |
|
2008 |
60 |
S1 |
p. S12- 1 p. |
artikel |
73 |
Prophylactic cranial irradiation (PCI) in extensive disease (ED) small cell lung cancer (SCLC): an audit of practice
|
Jain, P. |
|
2008 |
60 |
S1 |
p. S4- 1 p. |
artikel |
74 |
Pulmonary epithelioid trophoblastic tumour: a case report
|
O'Cearbhaill, R. |
|
2008 |
60 |
S1 |
p. S2- 1 p. |
artikel |
75 |
Quality of life after radiotherapy and steroids in patients with inoperable brain metastases from non-small cell lung cancer: the QUARTZ trial
|
Pugh, C. |
|
2008 |
60 |
S1 |
p. S29- 1 p. |
artikel |
76 |
Referral pathway determines lung cancer outcome
|
Beckett, P. |
|
2008 |
60 |
S1 |
p. S15- 1 p. |
artikel |
77 |
Reflections of a specialist mesothelioma multi-disciplinary team: a year on
|
Martin, J.E. |
|
2008 |
60 |
S1 |
p. S6- 1 p. |
artikel |
78 |
Results of a prospective database and a patient satisfaction survey, in the delivery of continuous hyperfractionated accelerated radiotherapy (CHART)
|
Klapper, R. |
|
2008 |
60 |
S1 |
p. S27- 1 p. |
artikel |
79 |
Risk of brain metastases in non-small cell lung cancer patients treated with induction chemotherapy
|
Johnston, R. |
|
2008 |
60 |
S1 |
p. S22-S23 2 p. |
artikel |
80 |
Routine day 8 blood tests are not necessary for patients with non-small cell lung cancer treated with oral vinorelbine-carboplatin chemotherapy
|
Swannie, H.C. |
|
2008 |
60 |
S1 |
p. S20- 1 p. |
artikel |
81 |
SELDI-TOF analysis of induced sputum from patients with lung cancer, ‘at risk’ control subjects and healthy control subjects
|
Magee, N.D. |
|
2008 |
60 |
S1 |
p. S8- 1 p. |
artikel |
82 |
Strategies for increasing surgical resection rates in lung cancer
|
Kirk, A.J.B. |
|
2008 |
60 |
S1 |
p. S1-S2 2 p. |
artikel |
83 |
Tarceva, how do we as professionals improve management of side effects? Development of tools for health professionals and patients
|
Brown, L. |
|
2008 |
60 |
S1 |
p. S26- 1 p. |
artikel |
84 |
Tarceva in relapsed non-small cell lung cancer: experience from Northwest England
|
Amir, E. |
|
2008 |
60 |
S1 |
p. S25-S26 2 p. |
artikel |
85 |
The effect of hypofractionated accelerated radiotherapy on pulmonary function in non small cell lung cancer
|
Brennan, S. |
|
2008 |
60 |
S1 |
p. S29- 1 p. |
artikel |
86 |
The effect of off-site MDT on lung cancer survival
|
Robinson, L. |
|
2008 |
60 |
S1 |
p. S14- 1 p. |
artikel |
87 |
The National Lung Cancer Audit in the United Kingdom: key messages after 2 years of data collection
|
Beckett, P. |
|
2008 |
60 |
S1 |
p. S15- 1 p. |
artikel |
88 |
The use of gefitinib in the management of non small cell lung cancer: a single institution experience
|
Srivastava, A. |
|
2008 |
60 |
S1 |
p. S25- 1 p. |
artikel |
89 |
Thymic pathology – five years experience in a specialist centre
|
Narula, A. |
|
2008 |
60 |
S1 |
p. S5- 1 p. |
artikel |
90 |
Time taken from initial referral to start of treatment in patients with small cell lung cancer – (SCLC) An audit of practice at University Hospitals of Leicester (UHL) NHS Trust in 2002 and 2006
|
De, A. |
|
2008 |
60 |
S1 |
p. S14- 1 p. |
artikel |
91 |
Using Fourier transform infrared (FTIR) spectroscopy to evaluate metabolic markers in sputum in patients with and without lung cancer
|
Ghosal, R. |
|
2008 |
60 |
S1 |
p. S11- 1 p. |
artikel |
92 |
Variability in lung cancer target volume definition between clinicians: a comparative study
|
Wills, L. |
|
2008 |
60 |
S1 |
p. S30- 1 p. |
artikel |
93 |
What is the role of palliative chemotherapy in metastatic non small cell lung cancer with brain metastases?
|
Ghafoor, Q. |
|
2008 |
60 |
S1 |
p. S22- 1 p. |
artikel |
94 |
What is the role of palliative chemotherapy in metastatic non small cell lung cancer with brain metastases?
|
Ghafoor, Q. |
|
2008 |
60 |
S1 |
p. S29- 1 p. |
artikel |
95 |
Why we needed to review the role of the lung cancer clinical nurse specialist (CNS) in Wales?
|
Horne, N. |
|
2008 |
60 |
S1 |
p. S13- 1 p. |
artikel |
96 |
Would you like your chemotherapy as a capsule to take at home? A study of oral vinorelbine
|
Crawford, S.M. |
|
2008 |
60 |
S1 |
p. S21- 1 p. |
artikel |